Microalgal Strain Stress Tolerance Patents: Leaders & Trends 2026
Microalgal strain stress tolerance patents: who holds the acid, osmotic and oxidative-stress claims
Concentrated at the top. the leading assignee alone accounts for 22 of 112 records, and the top 5 combined hold 58.0% of all records in scope. Filings rose from 5 in 2017 to a peak of 9 in 2022, before the +133% run from 3 filings in 2021 to 7 in 2024. Treat 2025 and 2026 as incomplete rather than declining.
- 1RES INST AT NATIONWIDE CHILDRENS HOSPITAL22
- 2CORBION BIOTECH INC15
- 3TERRAVIA HOLDINGS INC11
- 4TRANSALGAE ISRAEL11
- 5SOLAZYME INC6
See the full microalgal strain stress tolerance analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents on microalgal stress tolerance?
One assignee leads the ranked list with 22 of the 112 records in scope, well ahead of the fifth-ranked filer at 6 records and the tenth-ranked filer at 4. The top 5 assignees combined hold 58.0% of all records, and the top 10 combined hold 77.7%. This means the field is concentrated at the top but still has a long tail of smaller filers below the leading group, rather than being a two-party contest.
Is patent filing in microalgal strain stress tolerance growing or slowing down?
Filings grew from 3 in 2021 to 7 in 2024, a +133% increase over that three-year span, with a peak of 9 filings in 2022. The apparent drop-off in 2025 and 2026 is a publication-lag artefact, not a real slowdown: patent publication typically trails filing by around 18 months, so the most recent one to two years are always undercounted. Anyone tracking this field should treat 2024 as the last reliably complete year.
What technology areas do these patents actually claim?
Nearly all records (99.1%) touch C12N, the broad microorganism and genetic-engineering class, which functions as a baseline rather than a differentiator. The real technical split shows up further down: C12P fermentation and enzymatic synthesis methods appear in 56.3% of records, while downstream applications split across animal feed (A23K, 28.6%), fuel (C10L, 19.6%), specialty chemicals (C07C, 14.3%), medicinal preparations (A61K, 13.4%) and food or beverage uses (A23L, 11.6%).
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Microalgal Strain Stress Tolerance covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.